The CDC's vaccine advisory panel is expected to decide Friday whether all newborns should routinely get hepatitis B vaccines.

A federal vaccine advisory committee has voted to change a long-standing recommendation that all newborns in the United States receive the hepatitis B vaccine on the day they are born.

For many public health experts, the vote also marked the end of trust in the C.D.C. and its vaccine advisers.